Sales rep training impacted Q3 utilization, but September showed strong performance. Q4 expects modest volume impact from ongoing training. ASC pilot program progressing well, expanding in 2025 to boost hospital market penetration. Medicare audits have minimal growth impact. Company targets profitability with strong expense control and gross margin expansion.